Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality? [electronic resource]
- Eye (London, England) May 2009
- 997-1003 p. digital
Publication Type: Journal Article; Review
1476-5454
10.1038/eye.2008.428 doi
Diabetic Retinopathy--diagnosis Dyslipidemias--complications Fenofibrate--therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use Hypolipidemic Agents--therapeutic use Lipids--blood